SymBio submits IND for phase II trial of intravenous brincidofovir for pediatric AdV infections March 12, 2021
Sanofi and Translate Bio begin phase I/II study of MRT-5500 mRNA COVID-19 vaccine candidate March 12, 2021
Tilavonemab does not show evidence of efficacy in phase II study in progressive supranuclear palsy March 12, 2021